Is puberty an accelerator of type 1 diabetes in IL6-174CC females?

Diabetes

Volumn 54, Issue 4, 2005, Pages 1245-1248

  Gillespie, Kathleen M ^a,d   Nolsøe, Rima ^b   Betin, Virginie M ^a   Kristiansen, Ole P ^b   Bingley, Polly J ^a   Handrap Poulsen, Thomas ^b,c   Gale, Edwin A M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b STENO DIABETES CENTER   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN; HLA ANTIGEN CLASS 2; INTERLEUKIN 6;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; IL6 GENE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; PUBERTY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AGE OF ONSET; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; ESTROGENS; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBERTY; SEX FACTORS;

EID: 15944372189     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.4.1245     Document Type: Article

References (17)

1. Pundziute-Lycka A, Dahlquist G, Nystrom L, Arnqvist H, Bjork E, Blohme G, Bounder J, Eriksson JW, Sundkvist G, Ostman J, Swedish Childhood Diabetes Study Group: The incidence of type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 45:783-791, 2002
2. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC: 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950, 1994
3. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369-1376, 1998
4. Jahromi MM, Millward BA, Demaine AG: A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 20:885-888, 2000
5. Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ: Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Genes Immun 5:36-40, 2004
6. Kristiansen OP, Nolsoe RL, Larsen L, Gjesing AM, Johannesen J, Larsen ZM, Lykkesfeldt AE, Karlsen AE, Pociot F, Mandrup-Poulsen T: Association of a functional 17 beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet 12:1101-1110, 2003
7. Schork NJ, Fallin D, Lanchbury JS: Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 58:250-264, 2000
8. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710, 1997
9. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, Snuth AN, Sebag-Montefiore L, Merriman ME, Wilson AJ, Pritchard LE, Cucca F, Barnett AH, Bain SC, Todd JA: A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 19:297-300, 1998
10. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, Mitra M, Farmer J, Williams SR, Cox NJ, Bell GI, Risch N, Spielman RS: A second-generation screen of the human genome for susceptibility to insulin-dependent-diabetes mellitus. Nat Gene 19:292-296, 1998
11. Green A, Patterson CC, EURODIAB TIGER Study Group: Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44 (Suppl. 3):B3-B8, 2001
12. Warne GL, Carter JN, Faiman C, Reyes FI, Winter JS: Hormonal changes in girls with precocious adrenarche: a possible role for estradiol or prolactin. J Pediatr 92:743-747, 1978
13. Salobir B, Sabovic M: Interleukin 6 and antiphospholipid antibodies in women with contraceptive-related thromboembolic disease. Obstet Gynecol 104:564-570, 2004
14. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, AMra S: Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci 90:10193-10197, 1993
15. Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144, 2000
16. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
17. Gillespie KM, Valovin SJ, Saunby J, Hunter KM, Savage DA, Middleton D, Todd JA, Bingley PJ, Gale EAM: HLA class II typing of whole genome amplified mouth swab DNA. Tissue Antigens 56:530-538, 2000